SGLT2 inhibitors and cardiovascular risk: Lessons learned from the EMPA-REG Outcome study

Muhammad Abdulghani, Stefano Del Prato, Robert Chilton, Ralph A. De Fronzo

Research output: Contribution to journalArticlepeer-review

195 Citations (Scopus)

Fingerprint

Dive into the research topics of 'SGLT2 inhibitors and cardiovascular risk: Lessons learned from the EMPA-REG Outcome study'. Together they form a unique fingerprint.

Medicine & Life Sciences